The depression market

被引：27
作者：
Chancellor, Daniel [1 ]
机构：
[1] Datamonitor, London EC1R 3DA, England
来源：
NATURE REVIEWS DRUG DISCOVERY | 2011年 / 10卷 / 11期
关键词：
DISORDER;
D O I：
10.1038/nrd3585
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：809 / 810
页数：2
相关论文
共 5 条
  • [1] [Anonymous], 2011, HC00076003 DAT
  • [2] [Anonymous], DEPR
  • [3] Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]
  • [4] Agomelatine in the Treatment of Major Depressive Disorder Potential for Clinical Effectiveness
    Kennedy, Sidney H.
    Rizvi, Sakina J.
    [J]. CNS DRUGS, 2010, 24 (06) : 479 - 499
  • [5] Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report
    Rush, A. John
    Trivedi, Madhukar H.
    Wisniewski, Stephen R.
    Nierenberg, Andrew A.
    Stewart, Jonathan W.
    Warden, Diane
    Niederehe, George
    Thase, Michael E.
    Lavori, Philip W.
    Lebowitz, Barry D.
    McGrath, Patrick J.
    Rosenbaum, Jerrold F.
    Sackeim, Harold A.
    Kupfer, David J.
    Luther, James
    Fava, Maurizio
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (11) : 1905 - 1917
1